The president of Advent Medical Products, entrepreneur Randall Fincke has developed several innovative medical devices including monitors, clinicial devices and defibrillators. One of the many devices designed and developed was a compact, miniaturized and lightweight automated external defibrillator. Randall Fincke conducted extensive testing through clinical trials that resulted in his ultimately receiving FDA approval.Randall Fincke has designed and developed over his 25 year career medical devices that have contributed to saving lives in emergencies where cardiac care to normalize irregular heartbeats in life-threatening situations are present. For the public and corporate market, AEDs are designed so laypeople can use them with little, if any training in emergency situations while EMTs and Paramedics are on their way to the scene. Electrical energy is dispensed through the device to effect a normal heart rate.AEDs come with recorded voice and text instructions (on monitor screens) that instruct individuals with how to best proceed in using an AED in an emergency event which can effectively deliver a shock to restore a heartbeat. The most effective AED devices include the BiPhasic Wave Control technology patented by Randall Fincke which allows for the controlled escalation of energy and safer shock delivery in order to deliver better patient outcomes.
As the founder and president of Advent Medical, Randall Fincke has more 25 years of experience in management, marketing, and product development for medical devices. In 1996, Randall Fincke developed an innovative, wearable defibrillator weighing only one pound. Clinical trials resulted in 100 percent successful defibrillation. The company was sold for over $20 million. This marked a substantial improvement in external defibrillators. Traditionally, defibrillators were used by trained medical personnel in hospitals and for emergency medical services. Also available for use in patient's homes are small defibrillators, and wearable, vest-like defibrillators can be worn continually by patients at risk for cardiac arrest. Unlike automatic external defibrillators (AEDs), wearable defibrillators do not require another person to assist in their use.Built around a system that regularly and automatically monitors the heart, defibrillator vests use low-energy shocks to correct an abnormal heartbeat, and more intense, high-energy shocks to return a very fast and erratic heartbeat to normal. This automatic system helps to protect at-risk patients from heart attacks, severe damage from delayed treatment, and even death. Additionally, patients can now more easily assess the progression of their conditions from the comfort of their own homes.
Jan 2013 - Present
Founder and President
Advent Medical Products
1976 - 1977
Aug 1972 - May 1976
University of New Hampshire
Entrepreneur Randall Fincke has over 25 years of experience in the $6 B field of medical devices in the US and internationally. He serves as the president of Advent Medical Products, which is known for its innovative designs in monitors, clinical devices and defibrillators as an integral system which provides clinical information technology for hospitals, EMS Field, Public and Corporate settings, and US Military & Government. Before Randall Fincke assumed his current role, he designed and developed a miniaturized wearable defibrillator for Cadent Medical where he received his patent and FDA approval for this innovative medical device. Defibrillation involves the use of a medical device called a defibrillator. The medical equipment is designed to send an electric shock wave to an irregularly beating heart. In some instances, defibrillation is employed during ventricular fibrillation, a condition that develops from an erratic heartbeat. These medical devices are available in a variety of configurations and sizes. External defibrillators have two pads that are placed on the breast to deliver an electrical shock. Internal defibrillators also offer the technology where the defibrillation can be done on an automatic basis. The implanted device tracks the heart’s rhythms and dispenses a shock wave when the rhythm falls off course. In either case, a defibrillator’s primary purpose is to maintain the normal rhythms of the heart, and it can often be essential in saving lives.
An entrepreneur in the medical device sector, Randall Fincke heads Advent Medical Products, a firm dedicated to producing innovative healthcare solutions utilizing mobile, wireless, and ultra lightweight products designed to improve quality of care and help to reduce costs for hospital and EMS applications. Recently, the United States Food and Drug Administration (FDA) released a final ruling regulating wireless technologies intended for use by health care professionals and institutions. The ruling recognizes the quality standards expected in the industry for product developers like Randall Fincke to design and develop high quality products for their companies and their investors as they continue to move forward within the guidelines and approval of federal regulators. The new guidelines cover important issues like security and offer procedures for manufacturers to pre-submit their products to the FDA for approval. The FDA’s progress comes on the heels of another important milestone cleared by the Federal Communications Commission, which created a dedicated broadband spectrum for medical devices. The rapidly shifting environment has given incentive to companies both small and large to continue to invest in the development of wireless medical technology infrastructure. These changes clear the way for advanced patient mobility and extended in-home care.
With extensive experience in developing medical devices for clinical solutions and applications, Randall Fincke presently serves Advent Medical Products in his capacity as the CEO and founder. Randall Fincke’s company produces high-quality products and services for clients ranging from hospitals and EMS, to military & government applications, including wireless, mobile, and ultra lightweight products to improve efficiency and quality of clinical care. Recently the Institute of Electrical and Electronics Engineers (IEEE) Standards Association announced a strategic commitment to increase innovation in the area of personally connected, plug-and-play operative health technology. This decision will prepare the market for the inevitable influx of smart medical devices. The IEEE's decision comes on the heels of a study demonstrating that the American health system incurs many tens of billions of dollars of additional costs owing to the inability of medical devises to connect with one another. By supporting standards to enhance interoperability and connectivity among such devices, the IEEE hopes to improve outcomes, achieve savings, and stimulate health care technology innovation. A professional group, the IEEE brings together technical experts from a wide range of disciplines. The organization is committed to advancing technological development that benefits all humans.
Randall Fincke is a graduate of The University of New Hampshire with a BS in mechanical engineering and Tufts University with a MS in Engineering Design. He currently works with Advent Medical Products, a company he founded, to design and develop high quality medical devices. Over the course of a 25-year career in the medical device industry, Randall Fincke has acquired numerous patents and approvals from the U.S. Food and Drug Administration (FDA) for US distribution and necessary approvals into as many as 50 countries internationally. His products collectively have one of the industry’s highest FDA compliance rates. Recently the FDA has initiated a campaign to improve the overall safety and functionality of external defibrillators. This elevated standard of safety requires more effective designs, as well as a rededication to excellent manufacturing techniques. Likewise, new Medicare initiatives will hold hospitals responsible to meet higher quality care standards to avoid patient readmission rates within 30 days after being discharged from hospitals. More than 2,000 hospitals throughout the United States will be fined up to $227 million if they do not meet these higher care standards and Medicare benchmarks. The fines are part of an initiative that began in October 2012, which brought about a Medicare-driven shift in valuing quality of medical services and care over just quantity of care.
Randall Fincke is the founder of Cadent Medical and Advent Medical Products. At Cadent Medical, he developed a miniaturized defibrillator that weighed only 1 pound and could be transported easily. He has 25 years of experience in the field of medical devices, and has served in leadership, developmental, and marketing roles. Randall Fincke has secured a number of patents throughout his long and diverse career, including multiple innovations for medical devices and applications. The South Nassau Communities Hospital in New York recently became the first hospital on Long Island to use new cardiac resynchronization technology. Simply known as the Viva, the therapeutic device is capable of defibrillation with advanced shock reduction technology that allows for a more accurate distinction between acceptable and dangerous heart rhythms. The device also utilizes an algorithm to assess individual patient needs in real time, correctly identifying when the body may need to temporarily deviate from a normal heart rate. Recently approved by the FDA and after a one-year trial, the Viva displayed the device’s ability to reduce heart failure hospitalizations by 21%.